facebook


Go ProSubmit a deal
Submit
Series DScience

Science Secures $400 Million In Series D Funding To Expand Brain-Computer Interface Program

Science has raised $400 million in a Series D funding round at a $3.5 billion valuation, with participation from Khosla Ventures , the Ackman Oxman Institute, Tenet Healthcare , 885 Capital, Y Combinator and PLC Neuro…

By TradedVC Editorial1 min read

Science has raised $400 million in a Series D funding round at a $3.5 billion valuation, with participation from Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech, among others. The funding brings its total capital raised since its 2021 founding to more than $900 million and will support the European expansion of PRIMA, its brain-computer interface designed to restore form vision in patients with certain types of late-stage macular degeneration, its planned U.S. launch pending FDA approval, and further investments in research, manufacturing and its biohybrid neural interface program.

FOUNDER: Max Hodak

INVESTORS: Khosla Ventures, Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, PLC Neurotech

ROUND: Series D AMOUNT: $400,000,000 VALUATION: $3,500,000,000

HQ: Alameda, California

#VentureCapital #Science #MaxHodak #KhoslaVentures #TradedVC

ABOUT THE DEAL

Raise
$400M
Round
Series D
Company
Science
Desk
Deals
Filed
Nov 18, 2026
Founders
  • Max Hodak
Investors
ALL DEALS
Deal

Genesis AI Secures $500 Million In Series A Funding Led By Premji Invest And Khosla Ventures

Nov 18, 2026

Deal

August Labs Inc. Secures $12 Million In Seed Funding From Peak XV And Accel

Nov 17, 2026

Deal

Tiberius Aerospace Secures $85 Million In Series A Funding To Boost Defense Technology Development

Nov 17, 2026